SCHEMBL7606356

SCHEMBL7606356

CCCOCn1c(=O)c2c(ncn2Cc2ccccc2)n(CC(C)C)c1=O

nearest known ligand 0.67

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PDE1A P54750 2/20 0.67
PDE1B Q01064 2/20 0.67
PDE1C Q14123 2/20 0.67
SMN1; SMN2 Q16637 3/20 0.54
ALDH1A1 P00352 3/20 0.54
NPSR1 Q6W5P4 1/20 0.54
KMT2A Q03164 6/20 0.50
POLB P06746 1/20 0.50
HIF1A Q16665 1/20 0.50
ADORA2B P29275 1/20 0.49
RXFP1 Q9HBX9 1/20 0.49
MEN1 O00255 4/20 0.49
PDE2A O00408 1/20 0.48
HPGD P15428 1/20 0.47
TSHR P16473 1/20 0.47
MAPK1 P28482 1/20 0.47
ADORA3 P0DMS8 1/20 0.47
ADORA1 P30542 1/20 0.47
CNOT7 Q9UIV1 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7605727 0.90 KMT2A (0.55) PDE1APDE1BPDE1CSMN1; SMN2ALDH1A1
SCHEMBL1944565 0.87 PDE1A (0.82) PDE1APDE1BPDE1CSMN1; SMN2ALDH1A1
SCHEMBL27366264 0.85 PDE1A (0.69) PDE1APDE1BPDE1CSMN1; SMN2ALDH1A1
SCHEMBL7608741 0.85 POLB (0.53) PDE1APDE1BPDE1CSMN1; SMN2ALDH1A1
SCHEMBL7607915 0.84 ALDH1A1 (0.50) PDE1APDE1BPDE1CSMN1; SMN2ALDH1A1
SCHEMBL7606543 0.82 POLB (0.57) PDE1APDE1BPDE1CSMN1; SMN2ALDH1A1
SCHEMBL7608527 0.81 POLB (0.59) PDE1APDE1BPDE1CSMN1; SMN2ALDH1A1
SCHEMBL7606542 0.81 PDE1A (0.50) PDE1APDE1BPDE1CSMN1; SMN2ALDH1A1
SCHEMBL7604677 0.78 POLB (0.67) PDE1APDE1BPDE1CSMN1; SMN2ALDH1A1
SCHEMBL1944712 0.78 POLB (0.70) PDE1APDE1BPDE1CSMN1; SMN2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0812844-B1 Use of theophyllin derivatives for the treatment and prophylaxis fo shock conditions, novel xanthine compounds and processes for the production thereof HOECHST AG (DE) 2002-10-23 EP disclosed
US-6214992-B1 THEOPHYLLINE DERIVATIVES HAVING AT LEAST ONE ETHER FUNCTION IN METHYL RADICAL; XANTHINE COMPOUNDS WITH THIS SUBSTITUTION PATTERN USED AS ANTISHOCK TREATMENT HOECHST AKTIENGESELLSCHAFT (DE) 2001-04-10 US disclosed
EP-0812844-A2 Use of theophyllin derivatives for the treatment and prophylaxis fo shock conditions, novel xanthine compounds and processes for the production thereof HOECHST AKTIENGESELLSCHAFT (DE) 1997-12-17 EP disclosed